WOCKPHARMABSEWockhardt LtdHighPositive
Announced Thu, 21 May · 14:39 IST

ICRA Limited has upgraded the Credit Rating as given below: Long Term- Fund Based- Term Loan- Present Rating- A- (Stable); Previous Rating- BBB (Positive) Long Term/ Short Term- Fund ....

Rating UpgradedCredit & Debt View source PDF

WOCKPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-2.2%1-day move
₹1613.00
prior close
₹1600.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0-0.1+0.4-2.2+2.0+6.3+10.4+25.5+22.3+20.0+24.9+17.2
Up moveDown movePending
AI summary

ICRA Limited has upgraded Wockhardt's credit ratings across multiple instruments. The long-term rating for fund-based term loans has been upgraded from BBB (Positive) to A- (Stable). Similarly, long-term/short-term ratings for fund-based, non-fund based, and unallocated limits have all been upgraded from BBB (Positive)/A3+ to A- (Stable)/A2+. ICRA cited improved financial performance, a healthy market position in formulations in Indian and European markets, adequate liquidity, comfortable capital structure, and strengthened financial metrics from scale expansion of value-accretive products and new chemical entities (NCEs) as key reasons for the upgrade.

Likely market impact

This rating upgrade signals improved creditworthiness and financial health of Wockhardt. It may lower borrowing costs and improve investor confidence in the company's ability to meet debt obligations, which is a positive development for shareholders.